Tarceva® (erlotinib) is a prescription medication used to treat lung cancer and, when used in combination with another medicine, to treat cancer of the pancreas. The medication is approved for adults only and comes in the form of a daily tablet. Tarceva is sold in the following strengths:
Your dosage will be determined by your healthcare provider, based on factors such as the type of cancer being treated, whether you smoke, and whether you are taking other medications.
(For more details, click Tarceva. This article explores how the tablets work, what to expect while using them, and why they may not be suitable for everyone.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Tarceva [package insert]. Farmingdale, NY: OSI Pharmaceuticals, LLC;2013 May.
Tarceva Web site. Available at: http://www.tarceva.com/. Accessed October 23, 2011.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed October 22, 2011.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click